Taking stock of the drug industry, from the lab to the medicine chestJune 11, 2024Check out STAT+Sponsored By By Ed SilvermanPharmalot Columnist, Senior Writer Mel Evans/AP Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices Bernie Sanders first launched an investigation into Novo Nordisk's pricing practices for Ozempic and Wegovy in April. By Rachel Cohrs Zhang and Elaine Chen STAT+ | Biotech co-founded by entrepreneur Bob Langer is testing a new approach to developing obesity treatments Syntis' core approach is an oral polymer chemistry the team calls SYNT, which creates a coating over receptors in places like the stomach. By Allison DeAngelis Opinion: Blood tests for cancer detection aren't yet ready for prime time There's a big unknown with blood tests that can detect multiple types of cancer (aka liquid biopsy): Do they help people live longer? By Sanket S. Dhruva and Rita F. Redberg More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Pharmalot? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2024, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments